Mitchel Tate
Impact in
-
- Diabetes Treatment and Management
-
- Cardiovascular Function and Risk Factors
- Cardiac Fibrosis and Remodeling
Papers in
-
- Metabolism, Diabetes, and Cancer 5
- S100 Proteins and Annexins 2
-
- Cardiovascular Function and Risk Factors 10
- Cardiomyopathy and Myosin Studies 4
- Cardiac Fibrosis and Remodeling 4
- Co-authors
- Rebecca H. Ritchie (20 shared papers)Arpeeta Sharma (4 shared papers)Judy B. de Haan (4 shared papers)David Grieve (6 shared papers)Emma Robinson (5 shared papers)Brian D. Green (4 shared papers)James E. Vince (1 shared paper)Geetha Mathew (1 shared paper)
- Journals
- Frontiers in Physiology (3 papers)European Heart Journal (3 papers)Basic Research in Cardiology (2 papers)Clinical Science (2 papers)Cardiovascular Diabetology (2 papers)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Mitchel Tate
29 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 91
- Endocrinology, Diabetes and Metabolism 279
- Cardiology and Cardiovascular Medicine 308
- Clinical Biochemistry 69
- Geriatrics and Gerontology 22
- Molecular Biology 468
Countries citing papers authored by Mitchel Tate
This map shows the geographic impact of Mitchel Tate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchel Tate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchel Tate more than expected).
Fields of papers citing papers by Mitchel Tate
This network shows the impact of papers produced by Mitchel Tate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchel Tate. The network helps show where Mitchel Tate may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitchel Tate, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 175 | |
| 2 | 2018 | 140 | |
| 3 | 2015 | 89 | |
| 4 | 2017 | 82 | |
| 5 | 2017 | 79 | |
| 6 | 2021 | 72 | |
| 7 | 2015 | 62 | |
| 8 | 2017 | 61 | |
| 9 | 2000 | 55 | |
| 10 | 2017 | 40 | |
| 11 | 2020 | 37 | |
| 12 | 2019 | 37 | |
| 13 | 2017 | 35 | |
| 14 | 2016 | 31 | |
| 15 | 2014 | 28 | |
| 16 | 2019 | 28 | |
| 17 | 2021 | 19 | |
| 18 | 2022 | 19 | |
| 19 | 2021 | 17 | |
| 20 | 2019 | 15 |
About Mitchel Tate
Mitchel Tate is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery and Immunology, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (10 papers), Diabetes Treatment and Management (8 papers), Metabolism, Diabetes, and Cancer (5 papers), Cardiomyopathy and Myosin Studies (4 papers), Pancreatic function and diabetes (4 papers), Cardiac Fibrosis and Remodeling (4 papers), Traumatic Brain Injury and Neurovascular Disturbances (2 papers) and S100 Proteins and Annexins (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (279 citations), Cardiology and Cardiovascular Medicine (308 citations), Clinical Biochemistry (69 citations), Geriatrics and Gerontology (22 citations) and Molecular Biology (468 citations). Mitchel Tate has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Rebecca H. Ritchie, Arpeeta Sharma, Judy B. de Haan, David Grieve, Emma Robinson, Brian D. Green, James E. Vince, Geetha Mathew, Barbara J. McDermott and Miles J. De Blasio. Their work appears in journals such as Frontiers in Physiology, European Heart Journal, Basic Research in Cardiology, Clinical Science and Cardiovascular Diabetology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.